tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jeffrey La Rosa, 5 are a BUY (100%).
Analyst Jeffrey La Rosa, currently employed at LEERINK, carries an average stock price target met ratio of 50% that have a potential upside of 6.58% achieved within 124 days.
Jeffrey La Rosa’s has documented 10 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ABBV, AbbVie at 23-Sep-2025.
Analyst best performing recommendations are on ABBV (ABBVIE).
The best stock recommendation documented was for ABBV (ABBVIE) at 2/3/2025. The price target of $210 was fulfilled within 220 days with a profit of $26.03 (14.15%) receiving and performance score of 0.64.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Dec-2021
$300
$49.67 (19.84%)
$295
Buy Since 22-Jan-2023
$260
$9.67 (3.86%)
$235
Buy Since 05-Feb-2020
$288
$37.67 (15.05%)
$261
Buy Since 22-Jan-2024
$285
$34.67 (13.85%)
$265
Buy Since 17-Nov-2020
$282
$31.67 (12.65%)
$273
What Year was the first public recommendation made by Jeffrey La Rosa?
